High-dose methotrexate, thiotepa, orelabrutinib combined with or without rituximab in primary or secondary central nervous system diffuse large B-cell lymphoma: a single-center retrospective analysis.
- Impact Factor:
- 3.565
- Journal:
- Journal Of Cancer
- Translation or Not:
- no
- Included Journals:
- SCI


中南大学
Visits:
Home